Evidence map›Paper›PMID 32238887›Full record

ArticleActa pharmacologica Sinica2020

Cinnamaldehyde protects against rat intestinal ischemia/reperfusion injuries by synergistic inhibition of NF-κB and p53.

Marwan Almoiliqy, Jin Wen, Bin Xu, Yu-Chao Sun, Meng-Qiao Lian, Yan-Li Li, Eskandar Qaed, Mahmoud Al-Azab, Da-Peng Chen, Abdullah Shopit and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The role and mechanism of cinnamaldehyde in cancer.Journal of food and drug analysis · 2024
    Review
  17. Progress in the study of the correlation between sepsis and intestinal microecology.Frontiers in cellular and infection microbiology · 2024
    Review
  18. Article
  19. Review
  20. Current pharmaceutical design · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Marwan Almoiliqy *Pharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Jin Wen *Pharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Bin XuPharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Yu-Chao SunPharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Meng-Qiao LianPharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Yan-Li LiPharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Eskandar Qaed *Pharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Mahmoud Al-AzabPharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Da-Peng ChenLaboratory Animal Center, Dalian Medical University, Dalian, 116044, China.
Abdullah ShopitPharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Li WangPharmaceutical College, Dalian Medical University, Dalian, 116044, China.
Peng-Yuan SunPharmaceutical College, Dalian Medical University, Dalian, 116044, China. pysun@dmu.edu.cn.
Yuan LinPharmaceutical College, Dalian Medical University, Dalian, 116044, China. linyuandmu2008@qq.com.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our preliminary study shows that cinnamaldehyde (CA) could protect against intestinal ischemia/reperfusion (I/R) injuries, in which p53 and NF-κB p65 play a synergistic role. In this study, we conducted in vivo and in vitro experiments to verify this proposal. SD rats were pretreated with CA (10 or 40 mg · kg

Indexed as

AcroleinAnimalsCell LineInflammationIntestinesMaleMembrane Potential, MitochondrialMesenteric IschemiaMitochondriaOxidative StressProtective AgentsRats, Sprague-DawleyReperfusion InjuryTranscription Factor RelATumor Suppressor Protein p53AcroleincinnamaldehydeProtective AgentsRela protein, ratTp53 protein, ratTranscription Factor RelATumor Suppressor Protein p53apoptosiscinnamaldehydeinflammationmesenteric ischemia/reperfusion injurymitochondriaNF-κBoxidative stressp53

Identifiers

PMID32238887
PMCPMC7609352
OpenAlexW3014233917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.